SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-049656
Filing Date
2020-11-02
Accepted
2020-11-02 16:17:40
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20200930.htm 10-Q 1422818
2 EX-31.1 abio-ex311_8.htm EX-31.1 8580
3 EX-31.2 abio-ex312_7.htm EX-31.2 8538
4 EX-32.1 abio-ex321_6.htm EX-32.1 11190
  Complete submission text file 0001564590-20-049656.txt   3789616

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20200930.xml EX-101.INS 538132
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20200930.xsd EX-101.SCH 31831
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20200930_cal.xml EX-101.CAL 27548
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20200930_def.xml EX-101.DEF 81905
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20200930_lab.xml EX-101.LAB 276855
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20200930_pre.xml EX-101.PRE 189277
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 201280677
SIC: 2835 In Vitro & In Vivo Diagnostic Substances